Walleye Capital LLC Buys New Holdings in Plexus Corp. $PLXS

Walleye Capital LLC purchased a new position in Plexus Corp. (NASDAQ:PLXS) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,592 shares of the technology company’s stock, valued at approximately $8,296,000. Walleye Capital LLC owned approximately 0.10% of Plexus as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Covestor Ltd increased its holdings in shares of Plexus by 207.7% during the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after acquiring an additional 162 shares in the last quarter. Allworth Financial LP lifted its holdings in shares of Plexus by 20.8% in the 4th quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock worth $44,000 after purchasing an additional 52 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Plexus in the 3rd quarter valued at $72,000. Farther Finance Advisors LLC grew its position in Plexus by 114.7% in the 4th quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock valued at $75,000 after purchasing an additional 273 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after purchasing an additional 490 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Trading Up 1.3%

NASDAQ PLXS opened at $267.41 on Friday. The firm has a market capitalization of $7.16 billion, a P/E ratio of 39.44 and a beta of 0.90. The business has a fifty day simple moving average of $272.41 and a 200 day simple moving average of $240.31. Plexus Corp. has a 12 month low of $126.86 and a 12 month high of $307.06. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The business’s revenue was up 28.2% on a year-over-year basis. During the same period last year, the business earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, analysts predict that Plexus Corp. will post 7.11 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on PLXS shares. Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday. Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a report on Tuesday. Needham & Company LLC restated a “buy” rating and issued a $310.00 target price on shares of Plexus in a report on Friday. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a report on Friday, July 31st. Finally, Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. One analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. Based on data from MarketBeat, Plexus has a consensus rating of “Buy” and a consensus price target of $273.00.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Needham analyst David Williams reiterated a Buy rating and maintained a $310 price target, implying roughly 16% upside from the recently referenced share price. The analyst cited a stronger revenue outlook. Analyst reiterates Buy on Plexus as revenue outlook surges
• Positive Sentiment: Zacks Research upgraded Plexus from Hold to Strong Buy and sharply increased its EPS forecasts across fiscal 2026-2028. Estimates rose to $7.02 for fiscal 2026, $8.50 for fiscal 2027 and $9.42 for fiscal 2028, indicating expectations for accelerating profitability. Earnings estimates rising for Plexus
• Positive Sentiment: The company’s latest quarterly report showed EPS of $2.32 versus the $2.13 consensus estimate and revenue of $1.30 billion versus expectations of $1.23 billion. Revenue increased 28.2% year over year, while fourth-quarter guidance calls for EPS of $2.47 to $2.63.
• Positive Sentiment: Recent institutional activity was supportive, including new or expanded positions by BlackRock, Bank of New York Mellon and Victory Capital. Institutions and hedge funds collectively own approximately 94.45% of PLXS shares.
• Neutral Sentiment: Despite the bullish revisions, Plexus trades at a relatively elevated valuation, with a price-to-earnings ratio near 39. Consensus analyst coverage remains favorable overall, with an average rating of Buy and a consensus price target near $273.
• Negative Sentiment: Director Michael Schrock sold 4,000 shares for approximately $1.1 million, reducing his position by 9.02%. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, which reduces its significance as a discretionary bearish signal. Plexus director sells stock

Insider Activity

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the company’s stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $294.98, for a total value of $442,470.00. Following the completion of the sale, the chief executive officer directly owned 68,888 shares of the company’s stock, valued at approximately $20,320,582.24. This represents a 2.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of Plexus stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $272.17, for a total transaction of $138,806.70. Following the transaction, the insider directly owned 665 shares in the company, valued at approximately $180,993.05. This represents a 43.40% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 9,510 shares of company stock worth $2,625,182 over the last quarter. Insiders own 1.78% of the company’s stock.

Plexus Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.